Morphine antibody (HRP)
-
- Target See all Morphine products
- Morphine
- Reactivity
- Please inquire
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Morphine antibody is conjugated to HRP
-
Application
- ELISA
- Cross-Reactivity (Details)
- Morphine
- Purification
- Purified by Protein G.
- Immunogen
- KLH conjugated Morphine molecular modified
- Clone
- 2F11
- Isotype
- IgG
-
-
- Application Notes
- ELISA 1:500-1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Preservative
- Gentamicin sulfate
- Precaution of Use
- This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- Morphine
- Abstract
- Morphine Products
- Target Type
- Chemical
- Background
-
Synonyms: Morphine 6.
Background: Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.
-
